NEULANDLAB - Swing Trade Analysis with AI Signals
Back to List📊 Swing Trade Rating: 3.6
| Stock Code | NEULANDLAB | Market Cap | 20,693 Cr. | Current Price | 16,124 ₹ | High / Low | 19,748 ₹ |
| Stock P/E | 116 | Book Value | 1,257 ₹ | Dividend Yield | 0.07 % | ROCE | 18.7 % |
| ROE | 14.8 % | Face Value | 10.0 ₹ | DMA 50 | 13,967 ₹ | DMA 200 | 13,997 ₹ |
| Chg in FII Hold | -0.44 % | Chg in DII Hold | 1.12 % | PAT Qtr | 40.4 Cr. | PAT Prev Qtr | 96.5 Cr. |
| RSI | 69.7 | MACD | 555 | Volume | 2,17,884 | Avg Vol 1Wk | 70,574 |
| Low price | 10,578 ₹ | High price | 19,748 ₹ | PEG Ratio | 2.45 | Debt to equity | 0.16 |
| 52w Index | 60.5 % | Qtr Profit Var | -29.2 % | EPS | 139 ₹ | Industry PE | 30.2 |
NEULANDLAB shows moderate potential for swing trading. The RSI (69.7) and MACD (555) indicate strong bullish momentum, with the current price (₹16,124) well above both the 50 DMA (₹13,967) and 200 DMA (₹13,997). However, fundamentals raise caution: very high P/E (116 vs industry 30.2), declining quarterly PAT (₹40.4 Cr vs ₹96.5 Cr), and modest ROE (14.8%). While momentum favors short-term gains, valuation risks limit upside.
✅ Optimal Entry Price: Around ₹15,800–16,000, near short-term support.
📤 Exit Strategy: If already holding, consider profit booking near ₹16,800–17,200, or exit if price falls below ₹15,500 support.
🌟 Positive
- Strong momentum indicators (RSI and MACD).
- Trading volumes (2.17 lakh vs avg 70k) show high market activity.
- PEG ratio of 2.45 suggests moderate growth potential despite high valuation.
- DII holding increased (+1.12%), showing domestic institutional confidence.
⚠️ Limitation
- Very high valuation (P/E 116 vs industry 30.2).
- Quarterly PAT dropped significantly (₹40.4 Cr vs ₹96.5 Cr).
- Dividend yield is very low at 0.07%.
- FII holding decreased (-0.44%), showing reduced foreign investor interest.
📰 Company Negative News
- Quarterly profit variation (-29.2%) highlights earnings volatility.
📈 Company Positive News
- Strong momentum with price trading above both 50 DMA and 200 DMA.
- Healthy trading volumes indicate strong investor participation.
🏭 Industry
- Industry P/E at 30.2 shows NEULANDLAB trades at a steep premium.
- Pharmaceutical sector remains resilient but sensitive to global demand and regulatory changes.
✅ Conclusion
NEULANDLAB is a risky but potentially rewarding candidate for swing trading. Entry near ₹15,800–16,000 and exit around ₹16,800–17,200 may be considered. Strong momentum supports short-term gains, but high valuation and declining profits require strict stop-loss discipline. Suitable only for aggressive traders willing to manage elevated risk.